Statement Of Cash Flows [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166254

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
10,770 EUR
11,579 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for finance costs
164,000 EUR
Adjustments for decrease (increase) in other operating receivables
650,000 EUR
856,000 EUR
Adjustments for share-based payments
560,000 EUR
576,000 EUR
Adjustments for fair value losses (gains)
52,000 EUR
Other adjustments for non-cash items
16,000 EUR
1,000 EUR
Cash flows from (used in) operations
12,812 EUR
11,253 EUR
Interest paid, classified as operating activities
7,000 EUR
3,000 EUR
Income taxes paid (refund), classified as operating activities
349,000 EUR
Cash flows from (used in) operating activities
13,154 EUR
11,250 EUR
Cash flows from (used in) investing activities [abstract]
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
500,000 EUR
21,000 EUR
Other cash payments to acquire interests in joint ventures, classified as investing activities
1,270 EUR
Purchase of property, plant and equipment, classified as investing activities
101,000 EUR
107,000 EUR
Proceeds from sales of intangible assets, classified as investing activities
219,000 EUR
Purchase of intangible assets, classified as investing activities
638,000 EUR
954,000 EUR
Cash advances and loans made to other parties, classified as investing activities
1,157 EUR
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities
216,000 EUR
Cash flows from (used in) investing activities
1,239 EUR
3,075 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
14,337 EUR
Proceeds from issuing other equity instruments
2,832 EUR
Repayments of borrowings, classified as financing activities
62,000 EUR
Payments of lease liabilities, classified as financing activities
79,000 EUR
Interest paid, classified as financing activities
1,877 EUR
Cash flows from (used in) financing activities
7,838 EUR
62,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
6,555 EUR
14,387 EUR
Cash and cash equivalents
43,457 EUR
50,012 EUR
64,399 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.